Clinical Trials Browser

Phase 1/2 × Pharmaceutical Preparations × 90 days × Clear all

NCT07431216 2026-03-30

A Phase 1b/2a Study to Evaluate the Safety, Pharmacokinetics, and Objective Response of STAR-001 (LP-184) in Combination With Spironolactone in Supratentorial Glioblastoma at First Progression

Phase 1/2 Not yet recruiting

Glioblastoma